Raffaele Califano

257 total papers · 13.3k total citations
118 papers, 4.5k citations indexed

About

Raffaele Califano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Raffaele Califano has authored 118 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 75 papers in Pulmonary and Respiratory Medicine and 30 papers in Molecular Biology. Recurrent topics in Raffaele Califano's work include Lung Cancer Treatments and Mutations (70 papers), Lung Cancer Research Studies (67 papers) and Neuroendocrine Tumor Research Advances (29 papers). Raffaele Califano is often cited by papers focused on Lung Cancer Treatments and Mutations (70 papers), Lung Cancer Research Studies (67 papers) and Neuroendocrine Tumor Research Advances (29 papers). Raffaele Califano collaborates with scholars based in United Kingdom, Italy and United States. Raffaele Califano's co-authors include Sanjay Popat, Martin Reck, Simon Ekman, Fabrice Barlési, Silvia Novello, Keith M. Kerr, Solange Peters, Tanja Čufer, Johan Vansteenkiste and Suresh Senan and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Raffaele Califano

108 papers receiving 4.4k citations

Hit Papers

normalize citations (0→100%) normalize lifespan (0→100%) sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2016 1.9k citations Silvia Novello, Fabrice Barlési et al. Annals of Oncology profile →
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)

2021 470 citations Stephen V. Liu, Martin Reck et al. Journal of Clinical Oncology profile →
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study

2021 163 citations Michael Boyer, Mehmet Alı Nahıt Şendur et al. Journal of Clinical Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Raffaele Califano	3.2k	2.5k	1.1k	800	680	118	4.5k
Brett Hughes	2.3k 0.7×	2.1k 0.8×	815 0.8×	622 0.8×	694 1.0×	177	4.3k
Ticiana Leal	2.5k 0.8×	1.5k 0.6×	759 0.7×	578 0.7×	432 0.6×	98	3.2k
James Stevenson	3.5k 1.1×	2.8k 1.1×	1.2k 1.1×	374 0.5×	546 0.8×	136	5.8k
Stephen L. Graziano	2.8k 0.9×	2.9k 1.2×	1.3k 1.2×	559 0.7×	691 1.0×	116	5.1k
Hiroshi Nokihara	3.8k 1.2×	3.3k 1.3×	1.7k 1.5×	652 0.8×	932 1.4×	237	5.9k
Leora Horn	4.7k 1.4×	3.5k 1.4×	2.0k 1.8×	1.4k 1.7×	1000 1.5×	146	6.4k
Shadia I. Jalal	3.5k 1.1×	2.1k 0.9×	978 0.9×	395 0.5×	475 0.7×	133	4.8k
Gregory A. Masters	4.0k 1.2×	4.0k 1.6×	1.3k 1.2×	622 0.8×	840 1.2×	127	6.9k
Jyoti D. Patel	3.9k 1.2×	3.4k 1.4×	1.4k 1.3×	369 0.5×	830 1.2×	227	6.1k
Charu Aggarwal	2.6k 0.8×	1.9k 0.8×	876 0.8×	254 0.3×	793 1.2×	200	4.1k

Countries citing papers authored by Raffaele Califano

Since Specialization

Citations

This map shows the geographic impact of Raffaele Califano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Califano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Califano more than expected).

Fields of papers citing papers by Raffaele Califano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Califano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Califano. The network helps show where Raffaele Califano may publish in the future.

Co-authorship network of co-authors of Raffaele Califano

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Califano. A scholar is included among the top collaborators of Raffaele Califano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Califano. Raffaele Califano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact